ntegrins comprise a complex family of cell adhesion molecules involved in cell-cell and cell-extracellular matrix protein (ECMP)t interactions (1). At least three subfamilies have been defined on the basis of the association ofany of a number of at chains with a common /3 chain (2) . We have previously characterized two mAbs (H9.2B8 and 8.1802) that identified a novel integrin expressed on murine y/S and a//3 T cell lines and hybridomas as well as on T cells activated for prolonged periods of time (7-21 d) by mitogens or alloantigens. This integrin mediated adhesion to fibronectin, vitronectin, and fibrinogen, and the two mAbs in combination, as well as the tetrapeptide RGDS alone, could inhibit the binding of cell lines to these ECMP (3) . In the present report, we make use of a number of antisera to the vitronectin receptor (VNR) and demonstrate that this novel integrin is the murine homologue of the human VNR, thereby demonstrating for the first time that the VNR is present on mouse T lymphocytes and that the expression of this (33 integrin can be upregulated by activation. 
serum was purchased from Telios Pharmaceuticals, Inc. (La Jolla, CA). Rabbit antiserum to human GpIIIa (anti-a3 chain) was a gift from Dr. R. McKever (Oklahoma University, Norman, OK) and has previously been shown to react with mouse /33 integrin chains (7) . Clone M18/2.a .8, secreting rat IgG reactive with mouse 02 integrin chains (8) , was purchased from the American Type Culture Collection (Rockville, MD). Rat mAb to mouse LFA-1 (from clone M17/5.2) was purchased from Boehringer Mannheim Biochemicals (Indianapolis, IN). mAb H1 .2F3, which is reactive with a T cell activation antigen, has been described previously (9) .
Antipeptide Sera. Rabbit anti-peptide sera against the 000H-terminal sequences of human (31 (anti-/31) (NPKYEGK) (10) and VNR a chain (antiVNRa) (CEQLQPHENGEGNSET) (11) were prepared as previously described (12) .
Con A Stimulation of Splenocytes. Con A-activated spleen cells from 8-wk-old female C3H/HeN mice were prepared as previously described (3) .
Radioiodination andImmunoprecipitation Analysis. Cells were surface labeled with "'I using the previously described lactoperoxidase method (13) . Immunoprecipitations and immunodepletion experiments were performed as previously described (3) . Precipitates were analyzed on SDS-PAGE (7% acrylamide) slab gels in the presence of 5% 2-ME .
Two-dimensional Electrophoresis. Nonequilibrium pH gradient electrophoresis (NEPHGE) was performed according to O'Farrell et al . (14) under nonreducing conditions using pH 4-6.5 ampholines (Pharmacia Fine Chemicals, Piscataway, NJ) in the first dimension and SDS-PAGE (7.% acrylamide) in the second dimension.
Ligand Binding. Rat fibronectin (Calbiochem-Behring Corp., La Jolla, CA), rat fibrinogen (Sigma Chemical Co., St . Louis, MO), human vitronectin (Calbiochem-Behring Corp.), and rat collagen I (Sigma Chemical Co.) were coupled to CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals) . Peptide GRGDSPC (Telios Pharmaceuticals, Inc.) was coupled to thiopropyl-activated Sepharose
The Journal of Experimental Medicine " Volume 173 February 1991 343-347 4B (Pharmacia Fine Chemicals) . Magnetic laminin agarose was a gift from Advanced Magnetics (Cambridge, MA). Precipitation experiments were performed by incubating 250 p,l packed beads with 100 P,1 cell lysate for 60 min room temperature. The beads were washed in 0.5% NP-40 buffer (3) and integrins eluted with RGDS peptide (2 mg/ml) in 0.5% NP-40 buffer for 60 min. Immunoprecipitations using antiVNRet sera were performed with the eluate as previously described (3) .
Adhesion Assay. 96-well plates (Costar, Cambridge, MA) were coated with vitronectin (2 .0 Rg/ml) by incubating wells overnight at 37°C and then washing three times with binding buffer (PBS supplemented with 2.5 mg/ml BSA [Sigma Chemical Co.]). Remaining sites were blocked by adding 200 p.l binding buffer and incubating for 2 h at 37°C .
Resting T cells and Con A-activated lymphoblasts (10' cells/ml) were labeled with 300 PCi "Cr (Amersham Corp., Arlington Heights, IL) for 1 h at 37°C . The cells were then washed with HBSS and resuspended in 10 ml RPMI supplemented with 10% FCS for 30 min. After two washes, the cells were resuspended (5 x 105/ml) in binding buffer. The cell suspension (100 P.1) was added to plates precoated with human vitronectin (Telios Pharmaceuticals, Inc.). Adhesion was evaluated in the presence of RGDS or RGES (Peninsula Laboratories, Inc., Belmont, CA) or mAbs by adding these agents directly to the wells (100 P,1) . After a 2-h incubation at 37°C, the wells were washed three times with binding buffer. The level of adhesion was subsequently evaluated by the addition of 200 Al of 0.5% Triton X-100 and counting the lysate in a gamma counter. The percent cell adhesion is expressed as a percentage of the total counts per minute added to the well. Background binding represents the percent adhesion to plates coated with albumin alone. Mouse Vitronectin Receptor Is a T Cell Activation Antigen kD (/3 chain) and 140 kD (a chain) under nonreducing conditions, and that, upon reduction, the a chain is cleaved into 116-and 24-kD components (3) . To analyze the relationship of this heterodimer to other integrins, we performed a series of sequential immunoprecipitations. Cell lysates (T195 or T195/BW) were precleared of material reactive with antisera to (33 or VNRot chains or, as a negative control, normal rabbit serum (NRS). These precleared lysates were then immunoprecipitated with various integrin-reactive antisera followed by analysis on SDS-PAGE under reducing conditions ( Fig.  1 ) . After preclearing material reactive with NRS, anti-(31 serum precipitated a heterodimer with an a chain of 140 kD (intense band) and a a chain of 135 kD (faint band) (Fig.  1, lane 2) . Antibody to integrin 02 chains precipitated heterodimers of 98 kD (a chain) and 180 kD (a chain) (Fig.  1 , lane 3) that were identical in size to the chains precipitated by a mAb reactive with the a chain of LFA1 (Fig. 1, lane  4) . Three antisera to the VNR were used . Anti-03 and antiVNRci chain sera, as well as antiserum to purified human VNR, all precipitated a heterodimer with a a chain of 98 kD and an a chain of 116 kD (Fig. 1 , lanes 5, 6, and 8) .
The 24-kD component of the a chain can be visualized on 12% acrylamide gels (not shown) . The molecular sizes of the component VNR chains were similar to those of the integrin recognized by mAb H9 .2B8 (Fig. 1, lane 7) . To determine if mAb H9 .2B8 recognizes VNR, T195/BW cell lysates were cleared of material reactive with antisera to (33 chains or VNRci chains by repeated immunoprecipitations. Subsequent precipitations revealed that both anti-a3 and antiVNRct sera cleared the integrin recognized by mAb HUN (Fig. 1, B VNR is expressed by activated T cells. Spleen cells from C3H/HeN mice were grown in the presence of Con A (3 14g/ml) for 4 d and 11,2 (20 U/ml) for a further 10 d. These, and fresh spleen cells as nonactivated controls, were surface labeled with 1251 and cell lysates immunoprecipitated with NRS, mAb M18/2.a.8 to 02 chain, anti-,B3 chain serum, antiVNRci serum, and anti-human VNR serum. Immunoprecipirates were analyzed by SDS-PAGE with 7% acrylamide under reducing conditions. The position of prestained molecular mass markers is indicated on the right. The cells that proliferated in response to Con A were found by FACS analysis to be >95% Thy-1 * .
immunodepletion did not interfere with subsequent immunoprecipitations, as 01 integrins (not shown) and LFA 1 (Fig. 1, lanes 14 and 20) could still be precipitated from precleared lysates . Con A-activated Splenocytes Express VNR . We have previously shown by FRCS? analysis that the a chain recognized by mAb H9.2B8 (here shown to be VNRa) is present on a population of activated splenocytes (3) . In view of the fact that VNR has not previously been reported to be expressed by mouse lymphoid cells, we examined the structure of the receptor expressed by Con A-activated T cells. As shown in Fig. 2 , no material could be immunoprecipitated from lysates of resting lymphocytes with the antiVNRct peptide serum, while the typical LFA-1 heterodimer was seen with the anti-fl 2 precipitate (A) . In contrast, when similar studies were performed on lysates of T cells after 14 d of activation with Con A, all three antiVNR sera immunoprecipitated a 116-and 98-kD dimer (Fig. 2 B) . To determine if the VNR expressed by the activated splenorytes was functional, quantitative cell attachment studies were performed . About 30% of splenic T cells activated in vitro with Con A and 11,2 adhered to wells coated with vitronectin, and this binding could be completely inhibited by mAb 1-19 .2118 and by the RGDS peptide, but not by the RGES peptide or the control mAb H1 .2F3 (Table I) . No binding of resting T cells to vitronectin-coated plates could be detected .
Previous studies with human VNR have shown the VNR a chain may associate with (3 chains other than 03, namely ,131 (15, 16) , (3x (now named)35) (17) , Os (18) , and 03b (19) . Some of these novel a chains are not easily distinguished by their mobilities in one-dimensional SDS-PAGE, but can be clearly distinguished from 03 chains by pl (17, 19) . To examine whether some of the murine lymphoid VNR a chains might be associated with chains other than 03, we compared immunoprecipitations from T195/13W and Con A-activated splenocytes by NEPHGE analysis (Fig. 3) . It can be seen that both T195/13W and Con A-activated splenocytes apparently express only a single heterodimer when examined after precipitation with anti-a3 or antiVNRct sera, indicating that the VNR expressed by Con A-activated splenocytes is composed solely of the VNRa/f3 heterodimer.
VNR Expression by Activated T Cells Bind Multiple ECMP. Integrins have been shown to bind various ECMP (20) , and the key amino acid sequence in many of these binding specificities has been shown to be the RGD motif (1) . To determine the specificity of murine VNR, lysates from cells were reacted with ECMP-or RGD-containing peptide coupled to
The results are expressed as the percent cell adhesion . The background binding for the lymphoblasts was 7.3% and for the uncultured cells was 3.8%.
RGDS RGES
Inhibitor (Fig/ml Sepharose beads, eluted with RGDS peptide, and immunoprecipitated with antiVNRa sera. The results of such analyses shown in Fig. 4 indicate that VNR from Con A-stimulated splenocytes bound to RGD, fibronectin, fibrinogen, and vitronectin . Binding to all ligands was blocked by the presence of RGDS peptide (data not shown) . A similar binding pattern was seen with VNR expressed by T195/BW (Fig. 4) . Our previous studies (3), together with the results of this report of the mouse VNR, demonstrate that it is similar to the human VNR (21) . Both integrins comprise an a chain, which is cleaved upon reduction, and a /3 chain, which has an apparently larger molecular mass upon reduction than when nonreduced, indicative of intrachain disulfide bonds . The mouse VNR differs from the human VNR in that it is capable of binding to fibronectin in addition to fibrinogen and vitronectin . Binding to all three ECMP is mediated by the VNRa//33 heterodimer, and we have not been able to demonstrate any other chains associated with VNRa or /33 that may contribute to this unique binding specificity. In the case of human cells, adherence to fibronectin is associated with VNRa paired with the 01 chain (15, 16) and the /3x chain Mouse Vitronectin Receptor Is a T Cell Activation Antigen Figure 4 . Binding of VNR to extracellular matrix proteins. T195/BW and Con A-activated splenocytes were cell surface labeled with 1251 and cell lysates precipitated with fibrinogen, fibronectin, vitronectin, laminin, or collagen bound to Sepharose 4B . Integrins were eluted with 2 mg/ml RGDS peptide and immunoprecipitated with NRS or antiVNRa serum. Precipitates were analyzed at 7% SDS-PAGE under reducing conditions . The faint bands of 90, 130, and 170 kD were only seen in precipitates of material eluted from extracellular matrix protein-coupled beads . Their identities are currently under investigation. The position of prestained molecular mass markers is indicated on the right . (17, 22) ; however, the VNRa/(31 heterodimer does not mediate adherence to vitronectin, and the VNRa//3x heterodimer does not bind fibrinogen . One possible explanation for the difference is that the studies in man have characterized the VNR on nonlymphoid cells, whereas our studies in the mouse have characterized a VNR found on lymphoid cells.
Previous studies have shown that activation is required for integrin expression and/or function on T lymphocytes. Integrins that are expressed constitutively are only able to bind their ligand after T cell activation (20, (23) (24) (25) , whereas integrins not normally expressed by resting T cells, such as VLA 1 and VLA2, are induced after T cell activation. In this study, we have shown that only activated murine T cells express the VNR. These results differ from those of Klingemann and Dedhar (26) , who demonstrated VNR expression on resting human T cells. Although a species difference in the regulation of expression of the VNR on lymphoid cells may exist, these latter studies were performed with polyclonal antisera to the human VNR and have not, as yet, been confirmed with mAbs.
The function of VNR on activated T lymphocytes is still unclear; however, it seems likely that VNR functions as a costimulatory molecule (27) , as has been recently described for several other integrins (LFA-1, VLA-4, -5, -6) (23) (24) (25) .
